Researchers discovered how anti-cancer drugs called HDAC inhibitors help treat pancreatic cancer by altering scar tissue (fibroblast) development. The findings suggest HDAC inhibitors could be powerful tools in fighting pancreatic cancer — alone and in combination with other therapies.